Mangangot, Mark Caleb R.

HRN: 24-14-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2025
AMPICILLIN 500MG (VIAL)
11/29/2025
12/06/2025
IV
375
Q6h
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines